CONTROVERSIES IN THE TREATMENT OF PLASMA-CELL MYELOMA

被引:26
作者
BERGSAGEL, DE
机构
[1] UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA
[2] ONTARIO CANC INST, TORONTO M4X 1K9, ONTARIO, CANADA
关键词
D O I
10.1136/pgmj.61.712.109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:109 / 116
页数:8
相关论文
共 38 条
[1]  
ABRAMSON N, 1982, CANCER TREAT REP, V66, P1273
[2]  
ALEXANIAN R, 1983, BLOOD, V62, P572
[3]  
ALEXANIAN R, 1972, CANCER-AM CANCER SOC, V30, P382, DOI 10.1002/1097-0142(197208)30:2<382::AID-CNCR2820300213>3.0.CO
[4]  
2-C
[5]  
ALEXANIAN R, 1978, BLOOD, V51, P1005
[6]  
ALEXANIAN R, 1984, CANCER, V53, P583, DOI 10.1002/1097-0142(19840201)53:3<583::AID-CNCR2820530336>3.0.CO
[7]  
2-1
[8]   INEFFECTIVENESS OF FLUORIDE THERAPY IN MULTIPLE-MYELOMA [J].
不详 .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (24) :1283-+
[9]   EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS [J].
BARLOGIE, B ;
SMITH, L ;
ALEXANIAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) :1353-1356
[10]  
BELCH A, 1984, P AN M AM SOC CLIN, V3, P268